Treatment of ketamine-associated cystitis with chondroitin sulphate

British Journal of Nursing

Volumn 22, Issue 18 SUPPL., 2013, Pages

  Smart, Clare ^a   Kabir, Mohammed ^a   Pati, Jhumur ^a  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chondroitin sulphate; Cystitis; Ketamine bladder

Indexed keywords

EID: 84885575836     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2013.22.sup18.s4     Document Type: Article

References (18)

1. Agarwal A, Gupta D, Kumar M, Dhiraaj S, Tandon M, Singh PK (2006) Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br J Anaesth 96(5): 587-9
2. Chu PS, Kwok SC, Lam KM et al (2007) 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13(4): 311-3
3. Chu PS, Ma WK, Wong SC et al (2008), The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102(11): 1616-22
4. Chumbley G (2010) Use of ketamine in uncontrolled acute and procedural pain. Nurs Stand 25(15-17): 35-7
5. Colebunders B, Van Erps P (2008) Cystitis due to the use of ketamine as a recreational drug: a case report. J Med Case Rep 2: 219
6. Cottrell AM, Gillatt DA (2008) Ketamine associated urinary tract pathology: the tip of the iceburg for urologists? Br J Med Surg Urol 1(3): 136-8
7. Coyne KS, Lai JS, Zyczynski T, Kopp Z, Avery K, Abrams P (2004) An Overactive Bladder Symptom and Quality-of-Life Short Form: Development of rhe Overactive Bladder Questionnaire (OAB-Q) Short Form (SF). Paper given at the 34th joint meeting of the International Continence Society and the International Urogynaecological Association, 23-27 August 2004, Paris, France. International Continence Society, Bristol. www.ics.org/Abstracts/Publish/42/000181.pdf
8. Dillon D, Copeland J, Jansen K (2003) Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69(1): 23-8
9. Gauruder-Burmester A (2008) Treatment of Overactive Bladder with Chondroitin Sulphate - Results of a Clinical Trial. Paper given at 2nd International Expert Meeting, 2nd Oct 2008, Hohenlockstedt, Germany, organised by Gepan manufacturer Pohl Boskamp. http://news.eformation.de/v3/client/media/ 203/data/12562.pdf
10. Hoare J, Flatley J (2008) National Crime Survey. Drugs Misuse Declared: Findings From the British Crime Survey. England and Wales. October 2008. Home Office, London
11. Logan K (2011) Addressing ketamine bladder syndrome. Nurs Times 107(24): 18-20
12. Mason K, Cottrell AM, Corrigan AG, Gillatt DA, Mitchelmore AE (2010) Ketamineassociated lower urinary tract destruction: a new radiological challenge. Clin Radiol 65(10): 795-800
13. Naguib M, Adu-Gyanfi Y, Absood G H, Farag H, Gyasi H K.(1986) Epidural ketamine for postoperative analgesia. Can Anaesth Soc J 33(1): 16-21
14. Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cyststis: a new clinical entity. Urology 69(5): 810-12
15. Tanabalan C, Zaman F, Kabir M, Allemudder A, Smart C, Pati J (2012) Treatment of Recurrent Cystitis/Painful Bladder Syndrome and Overactive Bladder Symptoms with Chondroitin Sulphate 0.2% (Gepan). Abstract reference no EP436, presented at the 32nd Congress Meeting of the Societe Internationale d'Urologie, 3 October 2012, Fukuoka International Congress Centre, Japan.
16. Tsai TH, Cha TL, Lin CM et al (2009) Ketamine-associated bladder dysfunction. Int J Urol 16(10): 826-9
17. Wong SW, Lee KF, Wong J, Ng WW, Cheung YS, Lai PB (2009) Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J 15(1): 53-6
18. Wood D, Cottrell A, Baker S C et al (2011) Recreational ketamine: from pleasure to pain. BJU Int 107(12): 1881-4